Transforming Brazil’s drug discovery landscape with automated screening

This article and associated images are based on a poster originally authored by Ana Amélia Sanchez Iacia,José C. QuillesJunior, Bárbara C. dos Reis and Juliana Ferreirade Oliveira and presented at ELRIG Drug Discovery 2025 in affiliation with Brazilian National Laboratory of Biosciences (LNBio/CNPEM).

This poster is being hosted on this website in its raw form, without modifications. It has not undergone peer review but has been reviewed to meet AZoNetwork's editorial quality standards. The information contained is for informational purposes only and should not be considered validated by independent peer assessment.

CNPEM

Transforming Brazil’s drug discovery landscape with automated screening

Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

Exploring possibilities at LBE

High throughput screening (HTS)

Automated screening machinery.

Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

Target-ligand interaction assays

Molecule visualization with blue and yellow atoms and pink bonds.

Image Credit: Meta AI.

High content screening (HCS)

Cells with added coloring to make details distinct. (purple, yellow, green, red)

Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

  • Absorbance, fluorescence, and luminescence measurements
  • Fluorescent Polarization (FP) and Anisotropy (FA)
  • Differential Scanning Fluorimetry (DSF)
  • AlphaScreen and Time-resolved fluorescence (DELFIA and LANCE).
  • Fluorescent microscopy at a  large scale
  • Automated confocal microscopy

Plate readers

CLARIOstar

CLARIOstar. Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

EnVision

EnVision. Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

Microscopes

Operetta HCS

Operetta HCS. Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

Cytation5

Cytation5. Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

Liquid handlers

Multiflo

Multiflo. Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

Multidrop

Multidrop. Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

CELL::EXPLORER

Automated platform

A woman sits at a research desk in full PPE looking at results.

Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

The CELL: Explorer platform, housed in an NB2 environment, integrates a Janus MDT system, EnVision reader, Operetta high-content imager, automated incubator, barcode reader, and robotic arm to enable fully automated assay handling.

What do we offer?

TOTALLY FREE OF CHARGE!

Transforming Brazil’s drug discovery landscape with automated screening

Image Credit: Image courtesy of Ana Amélia Sanchez Iacia et al., in partnership with ELRIG (UK) Ltd.

Mamirauá Reserve for Sustainable Development, Amazon, Brazil. Sample collection site

    Mamirauá Reserve for Sustainable Development, Amazon, Brazil. Sample collection site. Photographed by Dr Marjorie Christine Paule Bruder (LNBio).

    • Easy access to innovation platforms
    • GLP principles
    • Legal instruments and traceability for benefit sharing
    • Co-development with local communities is stimulated
    • Over 8,000 samples derived from biodiversity

    The Brazilian Center for Research in Energy and Materials (CNPEM)

    The Brazilian Center for Research in Energy and Materials (CNPEM) is a Social Organization supervised by the Brazilian Ministry of Science, Technology and Innovation (MCTI).

    It is responsible for managing the Brazilian Synchrotron Light National Laboratory (LNLS), Brazilian Biosciences National Laboratory (LNBio), Brazilian Biorenewables National Laboratory (LNBR), the Brazilian Nanotechnology National Laboratory (LNNano) and, with support from the Ministry of Education (MEC), for managing Ilum School of Science.

    About ELRIG (UK) Ltd.

    The European Laboratory Research & Innovation Group (ELRIG) is a leading European not-for-profit organization that exists to provide outstanding scientific content to the life science community. The foundation of the organization is based on the use and application of automation, robotics, and instrumentation in life science laboratories, but over time, we have evolved to respond to the needs of biopharma by developing scientific programmes that focus on cutting-edge research areas that have the potential to revolutionize drug discovery.

    Comprised of a global community of over 12,000 life science professionals, participating in our events, whether it be at one of our scientific conferences or one of our networking meetings, will enable any of our community to exchange information, within disciplines and across academic and biopharmaceutical organizations, on an open access basis, as all our events are free of charge to attend!

    Our values

    Our values are to always ensure the highest quality of content, that content will be made readily accessible to all, and that we will always be an inclusive organization, serving a diverse scientific network. In addition, ELRIG will always be a volunteer-led organization, run by and for the life sciences community, on a not-for-profit basis.

    Our purpose

    ELRIG is a company whose purpose is to bring the life science and drug discovery communities together to learn, share, connect, innovate, and collaborate on an open-access basis. We achieve this through the provision of world-class conferences, networking events, webinars, and digital content.


    Sponsored Content Policy: News-Medical.Net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices, and treatments.

    Last Updated: Nov 26, 2025

    Citations

    Please use one of the following formats to cite this article in your essay, paper or report:

    • APA

      The Brazilian Center for Research in Energy and Materials (CNPEM). (2025, November 26). Transforming Brazil’s drug discovery landscape with automated screening. News-Medical. Retrieved on December 04, 2025 from https://www.news-medical.net/health/Transforming-Brazile28099s-drug-discovery-landscape-with-automated-screening.aspx.

    • MLA

      The Brazilian Center for Research in Energy and Materials (CNPEM). "Transforming Brazil’s drug discovery landscape with automated screening". News-Medical. 04 December 2025. <https://www.news-medical.net/health/Transforming-Brazile28099s-drug-discovery-landscape-with-automated-screening.aspx>.

    • Chicago

      The Brazilian Center for Research in Energy and Materials (CNPEM). "Transforming Brazil’s drug discovery landscape with automated screening". News-Medical. https://www.news-medical.net/health/Transforming-Brazile28099s-drug-discovery-landscape-with-automated-screening.aspx. (accessed December 04, 2025).

    • Harvard

      The Brazilian Center for Research in Energy and Materials (CNPEM). 2025. Transforming Brazil’s drug discovery landscape with automated screening. News-Medical, viewed 04 December 2025, https://www.news-medical.net/health/Transforming-Brazile28099s-drug-discovery-landscape-with-automated-screening.aspx.

    Comments

    The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
    Post a new comment
    Post

    While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

    Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

    Please do not ask questions that use sensitive or confidential information.

    Read the full Terms & Conditions.